Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma

Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling

(2021) E. Ococks et al.   ANNALS OF ONCOLOGY

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer

(2020) Bhishamjit S. Chera et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of residual disease and recurrence in early-stage non-small cell lung cancer (NSCLC) patients using sensitive personalized ctDNA sequencing assays.

(2020) Katrin Heider et al.   JOURNAL OF CLINICAL ONCOLOGY

Integrating genomic features for non-invasive early lung cancer detection

(2020) Jacob J. Chabon et al.   NATURE

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

(2020) Mark R. Openshaw et al.   BRITISH JOURNAL OF CANCER

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

(2020) Milan Radovich et al.   JAMA Oncology

Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database

(2019) Ji Hyae Lee et al.   JAMA Otolaryngology-Head & Neck Surgery

Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

(2019) Bhishamjit S Chera et al.   CLINICAL CANCER RESEARCH

Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

(2019) Carole Fakhry et al.   JAMA Oncology

Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA

(2019) Kaoru Onidani et al.   CANCER SCIENCE

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer

(2019) Glenn J. Hanna et al.   ORAL ONCOLOGY

Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases

(2019) Philipp Jurmeister et al.   Science Translational Medicine

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

(2019) Bradon R. McDonald et al.   Science Translational Medicine

Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy

(2019) Jason Chia‐Hsun Hsieh et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

(2019) Jeanne Tie et al.   JAMA Oncology

Comprehensive Characterization of Cancer Driver Genes and Mutations

(2018) Matthew H. Bailey et al.   CELL

Cell-Free Plasma DNA for Disease Stratification and Prognosis in Head and Neck Cancer

(2018) Markus A. Schirmer et al.   CLINICAL CHEMISTRY

Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature

(2018) M.T. Brands et al.   EJSO

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA

(2018) Davina Gale et al.   PLoS One

Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling

(2018) Vincent Plagnol et al.   PLoS One

Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy

(2018) Kerstin Zwirner et al.   RADIOTHERAPY AND ONCOLOGY

Epidemiology and Demographics of the Head and Neck Cancer Population

(2018) Natasha Cohen et al.   Oral and Maxillofacial Surgery Clinics of North America

Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts

(2016) Jacqueline A. Shaw et al.   CLINICAL CANCER RESEARCH

Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients

(2016) Agnieszka M. Mazurek et al.   ORAL ONCOLOGY

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma

(2016) Friederike Braig et al.   Oncotarget

Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

(2015) Gemma Gatta et al.   EUROPEAN JOURNAL OF CANCER

Comprehensive genomic characterization of head and neck squamous cell carcinomas

(2015)   NATURE

Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

(2014) Tanguy Y. Seiwert et al.   CLINICAL CANCER RESEARCH

Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma

(2014) Daria A. Gaykalova et al.   PLoS One

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Saliva and Plasma Quantitative Polymerase Chain Reaction–Based Detection and Surveillance of Human Papillomavirus–Related Head and Neck Cancer

(2014) Sun M. Ahn et al.   JAMA Otolaryngology-Head & Neck Surgery

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

(2013) Sarah-Jane Dawson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1

(2013) Anne T Nies et al.   Genome Medicine

Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

(2011) N. Agrawal et al.   SCIENCE

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

(2011) N. Stransky et al.   SCIENCE

Basaloid Squamous Cell Carcinoma of the Head and Neck is a Mixed Variant That Can be Further Resolved by HPV Status

(2009) Shanaz Begum et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up

(2009) Kapila Manikantan et al.   CANCER TREATMENT REVIEWS

Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial

(2009) Kathryn E. Lazure et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

(2008) Maura L. Gillison et al.   JNCI-Journal of the National Cancer Institute